Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 15/20 | 0.52 |
| ▸ | BTK | Q06187 | 13/20 | 0.49 |
| ▸ | PIM1 | P11309 | 2/20 | 0.43 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29448486 | 1.00 | JAK3 (0.52) | JAK3BTKPIM1PIM2USP30 | |
| SCHEMBL22496733 | 1.00 | JAK3 (0.52) | JAK3BTKPIM1PIM2USP30 | |
| SCHEMBL28918226 | 1.00 | JAK3 (0.52) | JAK3BTKPIM1PIM2USP30 | |
| SCHEMBL22497106 | 0.92 | BTK (0.54) | JAK3BTK | |
| SCHEMBL22496749 | 0.92 | BTK (0.54) | JAK3BTK | |
| SCHEMBL29448477 | 0.92 | BTK (0.54) | JAK3BTK | |
| SCHEMBL22496761 | 0.88 | JAK3 (0.53) | JAK3BTKUSP30 | |
| SCHEMBL29448488 | 0.88 | JAK3 (0.53) | JAK3BTKUSP30 | |
| SCHEMBL28918248 | 0.86 | JAK3 (0.56) | JAK3BTK | |
| SCHEMBL28918249 | 0.86 | JAK3 (0.56) | JAK3BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4656249-A2 | PYRAZOLOPYRIMIDINE DERIVATIVES AS KINASE INHIBITOR | Daewoong Pharmaceutical Co., Ltd. (KR) | 2025-12-03 | — | — | EP | disclosed |
| EP-3478687-B1 | PYRAZOLOPYRIMIDINE DERIVATIVES AS KINASE INHIBITOR | DAEWOONG PHARMACEUTICAL CO LTD (KR) | 2024-03-20 | — | — | EP | disclosed |
| EP-3950691-A1 | PYRAZOLOPYRIMIDINE DERIVATIVES AS KINASE INHIBITOR | Daewoong Pharmaceutical Co., Ltd. (KR) | 2022-02-09 | — | — | EP | disclosed |